Tap into the latest information and research by health organizations specializing in the treatment and cure of brain tumors.
Learn more about brain tumors and treatment, locate support groups nationwide, and find out about resources available to you.
Access educational information, online communities, financial resources, and even a place to share your story. Check the calendar for an upcoming Brain Tumor Walk near you.
The Musella Foundation for Brain Tumor Research and Information hosts this site to compile data and organize the brain tumor community. Download a guide for the newly diagnosed and explore financial resources.
EndBrainCancer Initiative/Chris Elliott Fund. EndBrainCancer.org
EndBrainCancer Initiative/Chris Elliott Fund assists patients so that they can receive immediate access to advanced treatment options, healthcare specialists, and support programs. The organization also educates the general public about brain tumors and brain cancer and advocates issues of national public health policy that impact the lives and welfare of patients.
Seek out local support groups that can provide positive support in your area.
Find support groups by state, compliments of the American Brain Tumor Association.
Browse online and telephone support groups, plus face-to-face sessions for New York, Connecticut, and New Jersey.
Join the Facebook group to stay up to date on Optune.Connect
Learn how nCompass supports Optune users every step of the way.Discover nCompass
Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.
If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:
If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:
Optune is not for everyone. Talk to your doctor if you have:
Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.
Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure™, the maker of Optune.
Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.
The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.
Talk to your doctor if you have any of these side effects or questions.
Please click here to see the Optune Instructions For Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.
Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).